Breadcrumb Home investors intimation stock exchanges Intimation to stock Exchanges Quick Explore Corporate Governance Shareholding Pattern Investor contact Year 2026-20272025-20262024-20252023-20242022-20232021-20222020-20212019-20202018-20192017-20182016-20172015-20162014-20152013-20142012-20132011-20122010-2011 Apply Allotment of 17,915 equity shares under ESOS 2013-A Scheme and the Cipla ESAR Scheme 2021 of the Company 14th May 2026 Intimation of Record Date for payment of dividend for FY2025-26 13th May 2026 Q4 FY26 Earnings conference call recording 13th May 2026 Recommendation of Final Dividend for FY-2025-26 13th May 2026 Appointment of Mr Sushrut Kulkarni as President & Global Chief – Integrated Product Development 13th May 2026 Grant of Stock Options and employee stock appreciation rights 13th May 2026 Appointment of Cost Auditors of the Company 13th May 2026 Outcome of Board Meeting held on 13th May, 2026 13th May 2026 Newspaper publications under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 06th May 2026 Cipla receives U.S. FDA approval for first AB Rated Generic of Ventolin® HFA 23rd Apr 2026 Pagination First page first Previous page ‹ Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Next page › Last page last BSE and NSE Quotes by TradingView The displayed data is not in real time and may have streaming delays.
